Table 1. Main Cardiovascular Risk Factors, Medication Use, and Treatment Goals by Framingham‐REGICOR Estimated Cardiovascular Risk Category
Low Risk (n=1499)Moderate Risk (n=2656)High Risk (n=1336)Very High Risk (n=475)P Value
LDL‐C
LDL‐C, mg/dL126±34130±33134±35142±34<0.001
Statin use, n (%)709 (47.3)1117 (42.1)477 (35.7)115 (24.2)<0.001
Meeting LDL‐C goals, n (%)841 (56.5)905 (34.3)203 (15.5)7 (1.5)<0.001
BP
SBP, mm Hg137.5±15.7146±14.9161.1±20.5158.2±17.6<0.001
DBP, mm Hg80.0±9.283.1±9.286.7±11.385.5±9.5<0.001
Use of antihypertensive drugs, n (%)1138 (76.0)1978 (74.5)1023 (76.6)352 (74.1)0.424
BP <140/90, n (%)867 (57.8)838 (31.6)161 (12.1)48 (10.1)<0.001
Smoking status
Current smokers, n (%)195 (7.0)358 (13.5)326 (24.4)280 (59.0)<0.001
Antiplatelet drugs
Use of antiplatelet drug, n (%)228 (15.2)504 (19.0)271 (20.3)111 (23.4)<0.001
  • Data expressed as mean±SD or n (%). LDL‐C goals according to estimated cardiovascular risk were defined as <130 mg/dL for low risk, <115 mg/dL for moderate risk, <100 mg/dL for high risk, and <70 mg/dL for very high risk. BP indicates blood pressure; DBP, diastolic blood pressure; LDL‐C, low‐density lipoprotein cholesterol; SBP, systolic blood pressure.